Statistics in regulatory science. (2019)
- Record Type:
- Book
- Title:
- Statistics in regulatory science. (2019)
- Main Title:
- Statistics in regulatory science
- Further Information:
- Note: Shein-Chung Chow.
- Authors:
- Chow, Shein-Chung, 1955-
- Contents:
- Preface 1. Introduction ; Introduction; Key Statistical Concepts; Complex Innovative Designs; Practical, Challenging, and Controversial Issues; Aim and Scope of the Book 2. Totality-of-the-Evidence; Introduction; Substantial Evidence; Totality-of-the-evidence; Practical and Challenging Issues; Development of Index for Totality-of-the-Evidence; Concluding Remarks 3. Hypotheses Testing Versus Confidence Interval ; Introduction; Hypotheses Testing; Confidence Interval Approach; Two One-sided Tests Procedure and Confidence Interval Approach; A Comparison; Sample Size Requirement; Concluding Remarks; Appendix of Chapter 3 4. Endpoint Selection ; Introduction; Clinical Strategy for Endpoint Selection; Translations Among Clinical Endpoints; Comparison of Different Clinical Strategies; A Numerical Study; Development of Therapeutic Index Function; Concluding Remarks 5. Non-inferiority Margin ; Introduction; Non-inferiority Versus Equivalence; Non-inferiority Hypotheses; Methods for Selection of Non-inferiority Margin; Strategy for Margin Selection; Concluding Remarks 6. Missing Data ; Introduction; Missing Data Imputation; Marginal/Conditional Imputation for Contingency; Test for Independence; Recent Development; Concluding Remarks 7. Multiplicity ; General Concepts; Regulatory Perspective and Controversial Issues; Statistical Methods for Multiplicity Adjustment; Gate-keeping Procedures; Concluding Remarks 8. Sample Size; Introduction; Traditional Sample Size Calculation; SelectionPreface 1. Introduction ; Introduction; Key Statistical Concepts; Complex Innovative Designs; Practical, Challenging, and Controversial Issues; Aim and Scope of the Book 2. Totality-of-the-Evidence; Introduction; Substantial Evidence; Totality-of-the-evidence; Practical and Challenging Issues; Development of Index for Totality-of-the-Evidence; Concluding Remarks 3. Hypotheses Testing Versus Confidence Interval ; Introduction; Hypotheses Testing; Confidence Interval Approach; Two One-sided Tests Procedure and Confidence Interval Approach; A Comparison; Sample Size Requirement; Concluding Remarks; Appendix of Chapter 3 4. Endpoint Selection ; Introduction; Clinical Strategy for Endpoint Selection; Translations Among Clinical Endpoints; Comparison of Different Clinical Strategies; A Numerical Study; Development of Therapeutic Index Function; Concluding Remarks 5. Non-inferiority Margin ; Introduction; Non-inferiority Versus Equivalence; Non-inferiority Hypotheses; Methods for Selection of Non-inferiority Margin; Strategy for Margin Selection; Concluding Remarks 6. Missing Data ; Introduction; Missing Data Imputation; Marginal/Conditional Imputation for Contingency; Test for Independence; Recent Development; Concluding Remarks 7. Multiplicity ; General Concepts; Regulatory Perspective and Controversial Issues; Statistical Methods for Multiplicity Adjustment; Gate-keeping Procedures; Concluding Remarks 8. Sample Size; Introduction; Traditional Sample Size Calculation; Selection of Study Endpoints; Multiple-Stage Adaptive Designs; Adjustment with Protocol Amendments; Multi-Regional Clinical Trials; Current Issues; Concluding Remarks 9. Reproducible Research ; Introduction; The Concept of Reproducibility Probability; The Estimated Power Approach; Alternative Methods for Evaluation of Reproducibility Probability; Applications; Future Perspectives 10. Extrapolation ; Introduction; Shift in Target Patient Population; Assessment of Sensitivity Index; Statistical Inference; An Example; Concluding Remarks; Appendix of Chapter 10 11. Consistency Evaluation ; Introduction; Issues in Multi-regional Clinical Trials; Statistical Methods; Simulation Study; An Example; Other Considerations/Discussions; Concluding Remarks 12. Drug Products with Multiple Components ; Introduction; Fundamental Differences; Basic Considerations; TCM Drug Development; Challenging Issues; Recent Development; Concluding Remarks 13. Adaptive Trial Design ; Introduction; What Is Adaptive Design; Regulatory/Statistical Perspectives; Impact, Challenges, and Obstacles; Some Examples; Strategies for Clinical Development; Concluding Remarks 14. Selection Criteria in Adaptive Dose Finding ; Introduction; Criteria for Dose Selection; Practical Implementation and Example; Clinical Trial Simulations; Concluding Remarks 15. Generic Drugs and Biosimilars ; Introduction; Fundamental Differences; Quantitative Evaluation of Generic Drugs; Quantitative Evaluation of Biosimilars; General Approach for Assessment of Bioequivalence/Biosimilarity; Scientific Factors and Practical Issues; Concluding Remarks 16. Precision and Personalized Medicine; Introduction; The Concept of Precision Medicine; Design and Analysis of Precision Medicine; Alternative Enrichment Designs; Concluding Remarks 17. Big Data Analytics ; Introduction; Basic Considerations; Types of Big Data Analytics; Bias of Big Data Analytics; Statistical Methods for Estimation of ∆ and μP - μN Concluding Remarks 18. Rare Disease Drug Development ; Introduction; Basic Considerations; Innovative Trial Designs; Statistical Methods for Data Analysis; Evaluation of Rare Disease Clinical Trials; Some Proposals for Regulatory Consideration; Concluding Remarks References Subject Index … (more)
- Edition:
- 1st
- Publisher Details:
- Boca Raton : Chapman & Hall/CRC
- Publication Date:
- 2019
- Extent:
- 1 online resource
- Subjects:
- 615.1900727
Drug development -- Statistical methods - Languages:
- English
- ISBNs:
- 9781000710816
9781000710038
9781000710427
9780429275067 - Related ISBNs:
- 9780367224769
- Notes:
- Note: Description based on CIP data; resource not viewed.
- Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.474567
- Ingest File:
- 02_625.xml